Testing of Personal Protective Equipment (PPE) for First Responders
2 other identifiers
interventional
12
1 country
1
Brief Summary
The purpose of this pilot study is to improve protection of first responders in case of biological disasters (e.g., pandemics, biotoxin incidents). For this goal we will compare two different kinds of personal protective equipment (PPE) to be used for a variety of exercises simulating activities of first responders in the field at two different environmental temperature profiles in a randomized cross-over study design. The goal is to find the best possible compromise between protection and ergonomics as well as to determine potential factors that might limit the performance of first responders while wearing PPE. This should provide guidance for future improvement of PPE and how biosensors for monitoring heart rate and body temperature in combination with AI models may reduce risk for first responders in the field.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 15, 2026
CompletedStudy Start
First participant enrolled
July 17, 2026
CompletedFirst Posted
Study publicly available on registry
July 24, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2027
ExpectedJuly 24, 2026
July 1, 2026
15 days
July 15, 2026
July 21, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (11)
Body weight
Mean change in body weight (kg) after completion/termination of the test
Baseline and at completion/termination (max. 6 hours after start)
Heart rate
Heart rate is measured using a blood pressure cuff before and after the test, as well as using sensors strapped next to the skin during the test.
Baseline, continuously during the test, and after completion of test (max 6 hours)
Blood pressure
Blood pressure is measured using a blood pressure cuff.
Baseline and after completion of test (max 6 hours)
Weight of Category III PPE suit
Weight of suit in kg at before and after the test to assess fluid loss.
Baseline and after completion of test (max 6 hours)
Body temperature
Body temperature in °C is measured using an in-ear thermometer before and after the test, as well as using sensors next to the skin during the test.
Baseline, during the test, and after completion of test (max 6 hours)
Humidity
Humidity is measured using sensors next to the skin.
For the duration of the test (max 6 hours)
Mean reaction time
Reaction time is measured using the ReactionX app, with 4 sensors that light up intermittently.
10 minutes
Semi-quantitative questionnaire on subjective wellbeing
The questionnaire uses a scale of 0-10 and is the last task in each of the 3 cycles of 6 tasks.
5 min
Resilience scale questionnaire RS-13
The internationally standardized questionnaire assesses psychological stress level, using a scale of 0-7 (do not agree - completely agree). It is completed before starting the test, and after completion or termination of test (after max 6 hours).
5 min
Error rate
Error rate is assessed by matching coloured and numbered caps to matching tubes and sorting them into predefined positions into a 81-position sample box. Number of errors is documented.
Max 20 min
Fine motor skills
Fine motor skills are assessed by matching coloured and numbered caps to matching tubes and sorting them into predefined positions in an 81-position sample box. Time needed to complete the task is documented.
Max 20 min
Study Arms (2)
Simulated tasks performed at 20-24°C
EXPERIMENTALParticipants wearing Category III PPE suit 1 or 2 perform 3 cycles of 6 tasks at 20-24°C
Simulated tasks performed at 30-34°C
EXPERIMENTALParticipants wearing Category III PPE suit 1 or 2 perform 3 cycles of 6 tasks at 30-34°C
Interventions
3 cycles of 6 different tasks at 2 different temperatures will be performed wearing the following Category III PPE suit: COMAT from Matisec, France. This suit will be worn with a face mask (Draeger) equipped with a P3 filter, as well as rubber boots and 2 layers of nitrile gloves.
3 cycles of 6 different tasks at 2 different temperatures will be performed wearing the following Category III PPE suit: EBO-10 from EGO, Czech Republic. This suit is a full body ventilated suit with powered air purifying respirators, and will be worn with rubber boots and 2 layers of nitrile gloves.
Eligibility Criteria
You may qualify if:
- The study will be open to employees or students of:
- the KAGES hospital, Graz, Austria
- the Medical University of Graz (Med Uni Graz), Austria
- the University of Graz, Austria
- the Red Cross
- the Police
- Fire brigade of the city of Graz
You may not qualify if:
- Pregnancy, allergy against latex or PVC, claustrophobia, acute infection, thrombophilia
- Chronic illnesses (not treated) such as asthma, COPD, cardiovascular diseases, diabetes mellitus and epilepsy,
- Participation in another study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Medical University of Grazlead
- European Unioncollaborator
Study Sites (1)
Medical University of Graz
Graz, Styria, 8010, Austria
Related Publications (1)
Loibner M, Hagauer S, Schwantzer G, Berghold A, Zatloukal K. Limiting factors for wearing personal protective equipment (PPE) in a health care environment evaluated in a randomised study. PLoS One. 2019 Jan 22;14(1):e0210775. doi: 10.1371/journal.pone.0210775. eCollection 2019.
PMID: 30668567BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Kurt Zatloukal
Med Uni Graz
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof. Dr. med. of Pathology
Study Record Dates
First Submitted
July 15, 2026
First Posted
July 24, 2026
Study Start
July 17, 2026
Primary Completion
August 1, 2026
Study Completion (Estimated)
January 1, 2027
Last Updated
July 24, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share